ScanSource (SCSC) Rallies On Growth Narrative While Valuation Still Sparks Debate
ScanSource (SCSC) has been drawing attention after a period of strong multi year total returns and solid reported revenue and net income figures. Investors are weighing whether the current share price still offers value.
See our latest analysis for ScanSource.
At a share price of $54.95, ScanSource has eased in the very short term, with the 1 day share price return down 3.49% and the 7 day share price return down 2.95%. Momentum over longer horizons remains firm, including a 90 day share price return of 25.66% and a 1 year total shareholder return of 32.99%.
If ScanSource’s run has you thinking about where else growth stories might emerge, this is an easy moment to scan the market using the 19 top founder-led companies
Bulls view ScanSource’s recent strength, along with growing revenue and net income, as evidence the stock merits its recent run. Bears focus on the latest pullback and potential valuation risk. Which case do the current numbers support when you look at today’s pricing?
Most Popular Narrative: 22.6% Undervalued
ScanSource’s most followed narrative points to a fair value of $71.00 per share, which sits above the recent close at $54.95 and frames the stock as undervalued on that view.
The company's strong balance sheet, high free cash flow conversion, and disciplined capital allocation (including ongoing share repurchases) provide substantial financial flexibility for accretive M&A and returning capital to shareholders, enabling outsized EPS growth even in moderate macro environments.
Curious what underpins that $71.00 fair value for ScanSource. The narrative leans heavily on recurring revenue, higher margins, and a future earnings multiple that assumes solid profit growth. The exact mix of revenue expansion, margin uplift, and share count reduction is doing the heavy lifting. The detailed playbook sits inside the full narrative.
Result: Fair Value of $71.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, ScanSource still faces pressure if hardware margins compress further or if vendors push more direct sales channels, which would limit the distributor’s role.
Find out about the key risks to this ScanSource narrative.
Another View on ScanSource’s Valuation
The first narrative pegs ScanSource at a fair value of $71.00, which points to meaningful upside from $54.95. A different angle comes from Simply Wall St’s DCF model, which puts future cash flow value closer to $54.13. That is slightly below today’s price and reads as modestly overvalued on this method. Which lens do you think fits your own assumptions best?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out ScanSource for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
Given the mixed signals around ScanSource’s current pricing, it helps to look past the headlines and focus on the underlying data. Our work highlights that ScanSource has 4 key rewards
Looking For More Investment Ideas Beyond ScanSource?
If ScanSource has sharpened your focus on opportunities, do not stop here. Broaden your watchlist now so you are not the one hearing about the best ideas after they move.
- Target resilient compounding potential by scanning companies with robust finances using the solid balance sheet and fundamentals stocks screener (48 results)
- Hunt for quality at a sensible price by reviewing companies that currently screen as attractively priced through the 52 high quality undervalued stocks
- Seek out future standouts before the crowd focuses on them by reviewing the screener containing 21 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com